(Press-News.org) The Pediatric Cancer Research Foundation (PCRF), a nonproﬁt focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced the 19 recipients of its 2023 research grants. The researchers will receive $1,730,000 in funding to explore new and safer treatments for pediatric cancers. Of the recipients, six scientists are receiving PCRF funding for the ﬁrst time.
For the balance, PCRF funding will support the continuation of ongoing research projects. Grant recipients will conduct their research at top institutions across the U.S, studying various types of childhood cancers. Many past researchers funded by PCRF have gone on to receive NIH funding after proving their initial concepts with the support of philanthropic dollars. “These grants encourage visionary researchers to advance science and develop the next generation of treatments to cure pediatric cancers and enhance quality of life,” said Jeri Wilson, Executive Director, Pediatric Cancer Research Foundation.
“The proposals we received this year are some of the most exciting we have ever had the privilege to consider and show great potential for moving us closer to desperately needed cures. Our only regret is that we didn’t have more money to invest.”
The 2023 grant recipients include:
• Susann Brady-Kalnay, PhD
Case Western Reserve University Hospital
Use of magnetic resonance ﬁngerprinting for determining response to immunotherapy in pediatric brain tumors
• Mitchell Cairo, MD
New York Medical College, Marie Fareri Children’s Hospital
Cancer genetics, tumor immunology, and targeted treatments for childhood and adolescent hematological malignancies and solid tumors
• Brian Crompton, MD
Dana-Farber Cancer Institute
Prospective validation of a prognostic liquid biopsy approach for pediatric Ewing Sarcoma
• Gregory Friedman, MD
University of Alabama at Birmingham
Directed drug delivery for pediatric High-Grade Glioma
• Josephine HaDuong, MD
Children’s Hospital of Orange County and University of California Irvine
Establishing a pediatric Medulloblastoma testing “pipeline”
• Alex Kentsis, MD
Memorial Sloan-Kettering Cancer Center
Curative epigenetic therapies of refractory pediatric Sarcomas
• Eugenie Kleinerman, MD
MD Anderson Cancer Center
A novel dendritic cell vaccine and anti-PD1 for Osteosarcoma therapy
• Audrey Lasry, MD
New York University School of Medicine
Modulating the immune microenvironment in pediatric Acute Myeloid Leukemia (AML)
• John Ligon, MD
University of Florida
Investigating the immune response to RNA-nanoparticle vaccines and use of these vaccines in combination with immune checkpoint inhibitors for metastatic Osteosarcoma
• Michelle Monje, MD, PhD
Lucile Packard Children’s Hospital Stanford Therapies for High-Grade Glioma
• Theodore Moore, MD
Mattel Children’s Hospital, UCLA
Phase I/II therapeutic research trials and development of new treatment modality for incurable brain tumors
• Marie Nelson, MD
Children’s Research Institute (CNMC)
Neoadjuvant checkpoint inhibition and cryoablation therapy in relapsed or refractory pediatric solid tumors
• Cody Nesvick, MD
Understand how SMARCB1 loss makes Atypical Teratoid Rhabdoid Tumor (ATRT) cells more vulnerable to treatment
• Ashley Plant-Fox, MD
Ann & Robert H. Lurie Children’s Hospital of Chicago
Combination immunotherapy for Diﬀuse Intrinsic Pontine Glioma (DIPG)
• Kathleen Sakamoto, MD, PhD
Lucille Packard Children’s Hospital Stanford
Targeting mitochondrial pathways in pediatric Acute Myeloid Leukemia (AML)
• Surojit Sarkar, PhD
Seattle Children’s Research Institute
Designing self-driving CAR T cell immunotherapies for metastatic solid tumors
• Elliot Stieglitz, MD
University of California, San Francisco Benioﬀ Children’s Hospital
Innovative tests to determine treatment responsiveness for Juvenile Myelomonocytic Leukemia (JMML)
• Masataka Suzuki, PhD
Baylor College of Medicine
Immunotherapy and CAR NK cell therapy for pediatric Sarcomas
• Rajkumar Venkatramani, MD
Texas Children’s Hospital
Molecular characterization of undiﬀerentiated Sarcomas
Sixty-seven applications were evaluated. The selected grant recipients were determined using the following criteria:
• Probability of an advance in prevention, diagnosis or treatment for the near-term
• Novelty of the concept and strategy
• Clarity of presentation
• Overall plan for bringing the research ﬁndings to clinical application
• Experience, background, and qualiﬁcations of the investigators
• Adequacy of resources and environment (facilities, patients, etc.)
About the Pediatric Cancer Research Foundation (PCRF)
Determined to transform pediatric cancer care by accelerating research breakthroughs, the Pediatric Cancer Research Foundation has one goal: to make it possible for all children facing childhood cancer to beat their disease and realize their full potential. Overseen by scientiﬁc thought leaders, its rigorous and competitive process for awarding research grants has contributed to pivotal advancements in the areas of Non-Hodgkin’s Lymphoma, Immunotherapy/CAR T-cells, Osteosarcoma, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia. For more information, please visit www.PCRF-kids.org or follow us @PCRF_KIDS.
About Childhood Cancer
One in every 285 children in the US will be diagnosed with cancer by the end of their teens and more children under 19 years of age will lose their lives to cancer than any other disease. Due to research advances, overall survival rates for pediatric cancer patients have grown by 70 percent in the past 40 years. Still, about 20 percent of kids with pediatric cancer do not survive today. Of those who do, two-thirds will suﬀer long-lasting chronic health conditions from their care and one quarter will face a severe or life-threatening later life eﬀect from their treatment.
This is because most current pediatric treatments are decades old, derived from adult oncology and are just too potent for developing bodies. Modern research focuses on advancing science that addresses the unique characteristics of pediatric cancers, including developing treatments for some cancers that presently have no known protocols. Achieving more breakthroughs, so all children with cancer emerge healthy after treatment, requires dramatically increasing research momentum – which starts with raising and investing more money in pediatric cancer research.
Pediatric Cancer Research Foundation announces 2023 grant recipients to accelerate discovery of new treatments for pediatric cancers
ELSE PRESS RELEASES FROM THIS DATE:
Absolute vs. relative efficiency: How efficient are blue LEDs, actually?
The absolute internal quantum efficiency (IQE) of indium gallium nitride (InGaN) based blue light-emitting diodes (LEDs) at low temperatures is often assumed to be 100%. However, a new study from University of Illinois Urbana-Champaign Electrical and Computer Engineering researchers has found that the assumption of always perfect IQE is wrong: the IQE of an LED can be as low as 27.5%. This new research, “Low temperature absolute internal quantum efficiency of InGaN-based light-emitting diodes”, was recently published in Applied Physics Letters. As ECE associate professor Can Bayram puts it, LEDs are the ultimate lighting source. ...
$4.5M grant to explore link between exercise, slowing down Alzheimer’s
A $4.5 million groundbreaking grant will fund research to explore a promising link between aerobic exercise and slowing the progression of Alzheimer's disease in a study led by an Arizona State University researcher. An estimated 6.7 million Americans age 65 and older are living with Alzheimer's disease, according to the Alzheimer’s Association's 2023 report. A $4.5 million groundbreaking grant from the National Institute on Aging will fund research exploring a promising link between aerobic exercise and slowing the progression of Alzheimer's. ...
New study uncovers role of previously unknown protein in obesity and diabetes
(Boston) – More than 40% of Americans are considered obese, and the trend continues to grow. The treatments or preventive options for obesity and obesity-associated diseases are limited. It is a major national healthcare and public health burden significantly increasing the risk of diseases such as diabetes, hypertension, and cancer and is linked to the severity of COVID-19. A research team from Boston University Chobanian & Avedisian School of Medicine has identified a novel druggable signaling molecule involved in obesity, a previously unknown protein (MINAR2) discovered in 2020 in the laboratory of Associate Professor of Pathology and Laboratory Medicine Nader Rahimi, ...
Study finds distinct patterns of pre-existing brain health characteristics in stroke patients
University of Cincinnati researchers are presenting abstracts at the European Stroke Organization Conference (ESOC) 2023, May 24-26 in Munich, Germany, including the results of the first large-scale assessment of radiological brain health in stroke patients in a population. Extensive research has helped pinpoint risk factors for initial stroke, but there is limited understanding about what the brains of stroke patients look like on a population level, according to UC’s Achala Vagal, MD, professor of neuroradiology. “Imaging can be an objective manifestation of the presence ...
Nanorobotic system presents new options for targeting fungal infections
Infections caused by fungi, such as Candida albicans, pose a significant global health risk due to their resistance to existing treatments, so much so that the World Health Organization has highlighted this as a priority issue. Although nanomaterials show promise as antifungal agents, current iterations lack the potency and specificity needed for quick and targeted treatment, leading to prolonged treatment times and potential off-target effects and drug resistance. Now, in a groundbreaking development with far-reaching implications for global ...
Bird brains can flick switch to perceive Earth’s magnetic field
Earth’s magnetic field, generated by the flow of molten iron in the planet’s inner core, extends out into space and protects us from cosmic radiation emitted by the Sun. It is also, remarkably, used by animals like salmon, sea turtles and migratory birds for navigation. But how? And why? A new study from researchers at Western’s Advanced Facility for Avian Research (AFAR), home to the world’s first hypobaric climatic wind tunnel for bird flight, explores a brain region called cluster N that migratory birds use to perceive Earth’s magnetic field. The team discovered the region is activated very ...
Food for thought: UH study highlights the role of clean technology in reducing food waste
Foodservice companies have long struggled with the challenge of what to do with all of their food waste. But researchers at the University of Houston Conrad N. Hilton College of Global Hospitality Leadership are shedding light on how clean technology can help those companies reduce waste and establish long-term sustainability goals. In a study published in the Journal of Hospitality & Tourism Research, Tiffany S. Legendre, an associate professor at Hilton College, and her team, interviewed 17 leaders of the country’s largest on-site foodservice providers (e.g., Aramark, Compass and Sodexo), ...
Illinois Tech announced as enrollment partner in NIH’s AI precision nutrition research, largest project of its kind
CHICAGO—May 26, 2023—Illinois Institute of Technology is one of 14 institutions chosen as an enrollment site for the National Institute of Health’s landmark initiative to advance nutrition research. Nutrition for Precision Health (NPH), powered by the All of Us Research Program, is working to engage 10,000 participants from diverse backgrounds across the United States with the aim of learning about how our bodies respond differently to food. NPH will use artificial intelligence–based ...
World leader in photonics gives talk at Aston University
Talk by one of the leading lights in optical communications Dr. Ming-Jun Li is currently a corporate fellow at Corning Incorporated He discussed installed optical fibres for ultra-wideband transmission systems. 26 May 2023 | Birmingham, UK Aston University has hosted one of the leading lights in optical communications and speciality optical fibres at its second international photonics workshop. Dr. Ming-Jun Li is currently a corporate fellow at Corning Incorporated in the USA and headed ...
GPS tracking reveals how a female baboon stopped using urban space after giving birth
A new study from Swansea University and the University of Cape Town provides the first documented evidence of a cessation in urban space use by a female baboon after giving birth: another example of how wild animals are adaptively responding to urbanisation. The study, recently published in the journal Ecology & Evolution, used GPS collars to track the movements of 13 chacma baboons in Cape Town, South Africa. The data revealed that when one collared female gave birth, she stopped using urban space without any significant change in daily distance travelled or social interactions that would be expected with general risk-sensitive behaviour during this ...